| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |